ReviewAging clinical and experimental research2023
Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties.
Review in Aging clinical and experimental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Cluster randomized trial of reablement strategies targeting sarcopenia (ReStart-S) in long-term care settings.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026Trial
- The effect of unaffected side resistance training on upper limb function reconstruction and prevention of sarcopenia in stroke patients: a randomized controlled trial.Scientific reports · 2024Trial
- Prevalence and associated factors of sarcopenia in stroke inpatients: a cross-sectional study with SarQoL-assessed quality of life.BMC neurology · 2026Article
- The association between sarcopenia and carotid artery plaque: a mediation analysis of inflammatory biomarkers.BMC endocrine disorders · 2026Article
- Longitudinal associations between changes in muscle strength, muscle mass, and physical performance and health-related quality of life in older adults: a four-year analysis from the SarcoPhAge cohort.European geriatric medicine · 2026Article
- Quality of Life in Patients with Sarcopenia: A Study of Prevalence and Associated Factors in Western Greek Population.Advances in experimental medicine and biology · 2026Article
- The influence of sarcopenia on health-related quality of life among older patients with gastrointestinal cancer: an assessment using the SarQoLAging clinical and experimental research · 2025Article
- Effect of diabetic kidney disease on sarcopenia and quality of life in patients with type 1 diabetes.Endocrine · 2025Article
- Cross-cultural adaptation and validation of the Sinhala version of SarQoLBMC geriatrics · 2025Article
- Patient-reported outcomes in sarcopenia: An ICFSR task force report.The Journal of frailty & aging · 2025Review
- Development and validation of an interpretable machine learning model for predicting low muscle mass in patients with rheumatoid arthritis: a multicenter study.Frontiers in medicine · 2025Article
- Prevention of Sarcopenia.Advances in experimental medicine and biology · 2025Review
- Evaluating the SarQoLHealthcare (Basel, Switzerland) · 2024Article
- Sarcopenia.Nature reviews. Disease primers · 2024Review
- Predictive value of sarcopenia components for all-cause mortality: findings from population-based cohorts.Aging clinical and experimental research · 2024Article
- Content validity of SarQoL, a quality of life questionnaire specific to sarcopenia.Aging clinical and experimental research · 2024Article
- Muscle parameters in fragility fracture risk prediction in older adults: A scoping review.Journal of cachexia, sarcopenia and muscle · 2024Article
- A Critical Review of Current Worldwide Definitions of Sarcopenia.Calcified tissue international · 2024Review
- Causal associations between the insulin-like growth factor family and sarcopenia: a bidirectional Mendelian randomization study.Frontiers in endocrinology · 2024Article
- Muscle strength, not muscle mass, determines the health-related quality of life in Indonesian women with systemic lupus erythematosus.Lupus science & medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
Patient perspectives are now widely recognized as a key element in the evaluation of health interventions. Therefore, the provision of specific and validated Patient Reported Outcome Measures that emphasize the lived experience of patients suffering from specific diseases is very important. In the field of sarcopenia, the only validated specific health-related quality of life (HRQoL) instrument available is the Sarcopenia Quality of Life questionnaire (SarQoL). This self-administrated HRQoL questionnaire, developed in 2015, consists of 55 items arranged into 22 questions and has currently been translated into 35 languages. Nineteen validation studies performed on SarQoL have consensually confirmed the capacity of SarQoL to detect difference in HRQoL between older people with and without sarcopenia, its reliability and its validity. Two further observational studies have also indicated its responsiveness to change. A short form SarQoL, including only 14 items has further been developed and validated to reduce the potential burden of administration. Research on the psychometric properties of SarQoL questionnaire is still encouraged as the responsiveness to change of SarQoL has not yet been measured in the context of interventional studies, as limited prospective data currently exist and as there is still not cut-off score to define a low HRQoL. In addition, SarQoL has mainly been used in community-dwelling older individuals with sarcopenia and would benefit to be studied in other types of populations. This review aims to provide to researchers, clinicians, regulators, pharmaceutical industries and other stakeholders a clear summary of comprehensive evidence on the SarQoL questionnaire published up to January 2023Query.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.